Mymetics Corp (MYMX)

[Work Harder]

Here it is

virosome component protein [Vaccinia virus]
GenBank: ALF36217.1

https://www.ncbi.nlm.nih.gov/protein/ALF36217

From that

c Centre for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany

d Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, Georgia, USA

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645304/

However, it is suggested that the VACV-IOC used in the 1970s originated from the Beaugency strain (J. A. Espmark to D. A. Henderson, correspondence on March 31, 1969, file 88-001-10, Sanofi Pasteur Archives [Connaught Campus]) that probably constituted the first animal-based vaccine samples imported to Brazil in 1887 from Chambon Institute, France


Affymetrix to Acquire eBioscience Nov. 30, 2011
- eBioscience is a leader in flow cytometry for oncology

https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2011/Affymetrix-to-Acquire-eBioscience/default.aspx

https://en.wikipedia.org/wiki/Affymetrix

In 2010 it only took a few days for Millipore Corporation (NYSE: MIL) to find a buyer willing to outbid Thermo Fisher Scientific Inc. (NYSE: TMO). Millipore agreed to be acquired by Merck KGaA (FWB: MRK) of Darmstadt, Germany. Merck will pay about $7.2 billion for Millipore, which tops a reported bid of $6 billion made by Thermo Fisher